Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)
1
presentation
0
follower
16
more
presentations
in this session
The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients
Longitudinal changes in troponin concentrations from mid- to late-life and left ventricular structure and function in late-life: The Atherosclerosis Risk in Community Study
Deaths and vascular outcomes with non-vitamin k oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system